OSSD OssDsign AB (publ)
OssDsign AB (publ) designs, manufactures, and sells implants and material technology for bone regeneration in the United States. The company offers OssDsign Catalyst, a nanosynthetic bone graft engages in dual bone formation pathways through fusion mass. OssDsign AB (publ) was founded in 2011 and is headquartered in Uppsala, Sweden.…
Industry Peers
Medical DevicesKey Statistics
About OssDsign (STO: OSSD)
›
OssDsign (STO: OSSD) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 38 employees.
The shares were at 2.980 SEK on 20 November 2026, down 74.0% over 52 weeks. Its 52-week range is 2.980 SEK to 13.38 SEK, and it trades at the bottom of that range.
Its market capitalisation is 329.67M SEK.
OssDsign reports return on equity of -16.4%, an operating margin of -35.8% and revenue down 18.8% year over year.
It holds more cash than debt, a net cash position of 137.36M SEK. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 2 analysts cover the stock; their mean price target of 5.800 SEK is 94.6% above the current price. The next earnings report is expected on 16 February 2027.